Review article
Venetoclax with low-dose cytarabine, a forgotten combination in patients with acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review
Lauro Fabián Amador-Medinaa,b,
, Erick Crespo-Solísc, Francisco Javier Turrubiates-Hernándezd, Karla Edith Santibañez-Bedollab
Autor para correspondência
lafab2013@gmail.com
Corresponding author at: Clinical Epidemiology Research Unit, OOAD Guanajuato, Mexican Social Security Institute, Blvd. Adolfo López Mateos Esq Paseo de los Insurgentes s/n, Los Paraisos, 37320 Leon, Guanajuato, Mexico.
Corresponding author at: Clinical Epidemiology Research Unit, OOAD Guanajuato, Mexican Social Security Institute, Blvd. Adolfo López Mateos Esq Paseo de los Insurgentes s/n, Los Paraisos, 37320 Leon, Guanajuato, Mexico.
a Clinical Epidemiology Research Unit, OOAD Guanajuato, Mexican Social Security Institute, Leon, Guanajuato, Mexico
b Department of Medicine and Nutrition, University of Guanajuato, Leon, Guanajuato, Mexico
c Christus Muguerza Hospital Faro del Mayab, Merida, Yucatan, Mexico
d Institute of Research in Biomedical Sciences, University Center of Health Sciences, University of Guadalajara, Guadalajara, Jalisco, Mexico
Lido
1379
Vezesque se leu este artigo
255
Total PDF
1124
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 56 | 9 | 65 |
| 2025 5 | 128 | 18 | 146 |
| 2025 4 | 95 | 19 | 114 |
| 2025 3 | 118 | 29 | 147 |
| 2025 2 | 104 | 32 | 136 |
| 2025 1 | 123 | 28 | 151 |
| 2024 12 | 133 | 28 | 161 |
| 2024 11 | 154 | 32 | 186 |
| 2024 10 | 174 | 39 | 213 |
| 2024 9 | 39 | 21 | 60 |
